ProductsBack/ELISA Kit for Chemokine C-X-C-Motif Receptor 4 (CXCR4)

ELISA Kit for Chemokine C-X-C-Motif Receptor 4 (CXCR4)

Name: ELISA Kit for Chemokine C-X-C-Motif Receptor 4 (CXCR4)
SKU: SEA940HU_U80
Availability: BackOrder

SEA940HU

Product group Assays

Overview

Supplier
Cloud-Clone Corp.
Product Name
ELISA Kit for Chemokine C-X-C-Motif Receptor 4 (CXCR4)
Delivery Days Customer
12
Assay Detection Range
0.156-10ng/mL
Assay Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Chemokine C-X-C-Motif Receptor 4 (CXCR4) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays): 3 samples with ...
Assay Sensitivity
The minimum detectable dose of this kit is typically less than 0.056ng/mL
Assay Test Principle
The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Chemokine C-X-C-Motif Receptor 4 (CXCR4). Standards or samples are then added to the ...
Assay Time
3h
Certification
Research Use Only
UNSPSC
41116158

Ogłodek EA, Szota AM, Just MJ, et al. A study of chemokines, chemokine receptors and interleukin-6 in patients with panic disorder, personality disorders and their co-morbidity. Pharmacol Rep. 2016,68(4):756-63. doi: 10.1016/j.pharep.2016.03.017
Read this paper
Ogłodek EA, Szota AM, Moś DM, et al. Serum concentrations of chemokines (CCL-5 and CXCL-12), chemokine receptors (CCR-5 and CXCR-4), and IL-6 in patients with posttraumatic stress disorder and avoidant personality disorder. Pharmacol Rep. 2015,67(6):1251-8. doi: 10.1016/j.pharep.2015.05.023
Read this paper
Ogłodek EA, Szota A, Just MJ, et al. Comparison of chemokines (CCL-5 and SDF-1), chemokine receptors (CCR-5 and CXCR-4) and IL-6 levels in patients with different severities of depression. Pharmacol Rep. 2014,66(5):920-6. doi: 10.1016/j.pharep.2014.06.001
Read this paper
Chiva-Blanch G, Condines X, Magraner E, et al. The non-alcoholic fraction of beer increases stromal cell derived factor 1 and the number of circulating endothelial progenitor cells in high cardiovascular risk subjects: a randomized clinical trial. Atherosclerosis. 2014,233(2):518-524. doi: 10.1016/j.atherosclerosis.2013.12.048
Read this paper